Built by a Parkinson’s sufferer, MyHealthPal tracks symptoms, creates research data.
The development and availability of wearables is running hand in hand with the exploding interest in the digital health space. Managing our health via apps and devices is slowly becoming the norm. And patients that need to monitor their condition day-to-day have even more to benefit from this powerful combination. Startups are of course entering this space in droves.
The latest is a startup which launches out of stealth today: MyHealthPal, an iOS app and analytics platform that enables people with long-term health conditions to manage their condition, is initially focusing on Parkinson’s Disease, but could be applied similar diseases.
It has now secured an initial seed funding of £500,000, and launched a trial with the highly respected Mount Sinai Hospital in New York.
The investors include a mix of private and institutional investors. Venture Capital firm Proxy Ventures is participating. However, the lead investors are Andrew MacKay, chairman of Yapp Brothers and previously director of IG Group Holdings, and angel investor Will Armitage. Health and medical business expert Terence Bradley join them.
It is often the case that entrepreneurs who want to address problem they have encountered personally create the best startups. In founder Mike Barlow’s case, it could not be more personal. The tech entrepreneur founded the company after being diagnosed with Parkinson’s at age 41, two years ago. He discovered there was no effective way to manage and measure the effectiveness of his medication, track symptoms, log mood, diet, exercise and other metrics and their impact on his quality of life.
So MyHealthPal aggregates patients’ day-to-day data points into a dashboard for the patient.
Now, the space is already well populated by mpower, Gluko and GlucoSuccess. Not to mention the launch of Apple’s HealthKit and ResearchKit. NEA is also a significant investor in this space, amongst others.
However, myHealthPal thinks it has a better solution because it has been designed by an actual patient for other patients.
The clever move with this startup is that is also allows users to donate their anonimized data in return for a share of the revenues that data generates to scientific research institutions and charities supporting research and care. Boom. This is like the share economy for patients.
To achieve this, MyHealthPal says it complies with EU and US data privacy requirements and uses HIPAA certified technology.
Mary Keane-Dawson, Group CEO, MyHealthPal, says ultimately, MyHealthPal analytics platform will enable research and data scientists “to query large volumes of data, which is why MyHealthPal is such an interesting business for both investors and medical research institutions.”
The startup says it is now in “advanced discussions” with other institutions and charities in both the UK and US.
The ‘market’ if you can call it that, is, unfortunately big. There are over 421 million people living with long-term chronic conditions such as Parkinson’s Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Irritable Bowel Disease, HIV/AIDS and Alzheimer’s according to the World Health Organisation.